No definition available.
Congenital malformations of gallbladder, bile ducts and liver
Q17_CONGEN_MALFO_GALLB_BILE_DUCTS_LIVER
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
395 |
4. Check minimum number of eventsNone |
395 |
5. Include endpointsNone |
395 |
6. Filter based on genotype QC (FinnGen only) |
355 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM1
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q3[8-9]|Q4[0-5]
- Name in latin
- Malformationes congenitae vesicae biliaris, ductuum biliarium et hepatis
Similar endpoints
↥List of similar endpoints to
Congenital malformations of gallbladder, bile ducts and liver
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations of the digestive system
- Other congenital malformations of the digestive system, including avohilmo
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1971 | 1312 | 646 |
| Only index persons | 1660 | 1143 | 517 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 55.99 | 55.62 | 56.39 |
| Only index persons | 56.48 | 55.83 | 57.89 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 355 | 245 | 110 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.05 |
| Median age at first event (years) | 55.34 | 53.36 | 59.76 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 368
- Matched controls
- 3680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q44.6
ICD-10 Finland
Cystic disease of liver
+∞
314.6
255
*
127
Kela drug reimbursment
Transplant complication
37.4
116.7
75
25
K76.80
ICD-10 Finland
Hepatic cyst
208.9
105.6
105
7
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
64.5
98.4
55
10
Z94.0
ICD-10 Finland
Kidney transplant status
52.6
92.7
54
12
L04AD02
ATC
tacrolimus; systemic
42.9
89.9
55
15
K83.0
ICD-10 Finland
Cholangitis
41.3
76.3
47
13
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.2
74.7
156
341
L04AA06
ATC
mycophenolic acid; systemic
22.1
71.5
55
29
A11CC03
ATC
alfacalcidol; systemic
19.5
70.9
58
35
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
8.1
66.6
108
179
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
200.3
65.4
66
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
18.6
63.6
53
33
A05AA02
ATC
ursodeoxycholic acid; oral
21.9
62.5
48
25
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
30.6
61.0
41
15
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
19.3
60.2
49
29
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
21.6
57.1
44
23
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
140.0
56.7
59
5
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
17.2
54.6
47
31
TK800
NOMESCO Finland
Hemodialysis
21.4
54.4
42
22
JN3AD
NOMESCO Finland
Abdominal CT examination
6.0
50.8
113
253
Z94.4
ICD-10 Finland
Liver transplant status
123.4
50.3
53
5
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.5
49.7
82
136
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
+∞
48.0
45
*
L04AD01
ATC
ciclosporin; systemic
14.7
45.0
42
32
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
18.3
42.4
35
21
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.9
36.7
178
710
JJ5KT
NOMESCO Finland
Sclerotherapy of liver cyst
+∞
36.0
34
*
JJA31
NOMESCO Finland
Laparoscopic marsupialisation of cyst of liver
+∞
35.0
33
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
99.5
33.4
36
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
180.7
32.3
33
*
Q44.29
ICD-10 Finland
Atresia of bile ducts
+∞
31.7
30
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
11.6
30.9
33
31
JKD50
NOMESCO Finland
Hepatoportoenterostomy
+∞
30.6
29
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
31.9
30.5
40
14
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
11.2
30.2
33
32
L04AX01
ATC
azathioprine; systemic
7.7
29.5
44
64
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
7.8
29.5
43
61
H02AB04
ATC
methylprednisolone; systemic
4.2
29.3
95
280
JAH00
NOMESCO Finland
Laparotomy
8.2
27.2
38
51
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.2
26.9
204
1026
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
26.8
72
183
RD210, ,
NOMESCO Finland
8.1
26.4
37
50
WX402
NOMESCO Finland
General anaesthesia
3.3
26.1
151
646
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
46.5
25.0
30
7
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
6.0
24.2
46
86
TPH07
NOMESCO Finland
Cathetrisation of artery
3.9
23.4
81
248
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
+∞
23.2
22
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
32.5
23.2
30
10
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.3
23.0
41
72
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.9
22.6
29
35
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
22.4
21.6
31
15
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
21.6
223
1280
Z2446
NOMESCO Finland
Social worker
4.1
21.4
68
195
Q44.4
ICD-10 Finland
Choledochal cyst
+∞
21.0
20
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
27.4
20.8
28
11
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.4
20.5
43
88
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
25.1
20.3
28
12
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.3
20.2
43
89
JJ5AT, ,
NOMESCO Finland
210.9
19.8
20
*
A12AA04
ATC
calcium carbonate; oral
16.0
19.3
31
21
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.3
19.1
55
146
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
105.5
18.7
20
*
H02AB09
ATC
hydrocortisone; systemic
6.3
18.7
33
57
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
18.5
95
370
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
23.2
18.4
26
12
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.5
18.4
31
51
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
28.4
18.0
24
9
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
188.7
17.7
18
*
R50.9
ICD-10 Finland
Fever, unspecified
3.0
17.6
99
405
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
22.2
17.5
25
12
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
17.5
141
695
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
33.3
17.2
22
7
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
17.2
114
509
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
37.0
16.9
21
6
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.3
16.8
29
49
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
7.7
16.7
24
33
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
94.4
16.7
18
*
J01MA02
ATC
ciprofloxacin; systemic
2.5
16.7
164
886
B03XA02
ATC
darbepoetin alfa; parenteral
13.7
16.4
28
22
R4110
NOMESCO Finland
Physiotherapy
2.6
16.4
148
766
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
6.1
16.1
29
51
N18.8
ICD-10 Finland
Other chronic renal failure
12.5
15.8
28
24
Z49.0
ICD-10 Finland
Preparatory care for dialysis
30.1
15.3
20
7
C03CA01
ATC
furosemide; systemic
2.5
15.2
128
638
205
Kela drug reimbursment
Chronic hypertension
2.6
14.7
110
516
ZXD05
NOMESCO Finland
Urgent procedure
2.5
14.7
135
699
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.9
14.6
23
35
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.7
14.4
99
445
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.3
14.2
38
95
Q44.1
ICD-10 Finland
Other congenital malformations of gallbladder
+∞
13.6
13
*
V03AE02
ATC
sevelamer; oral
35.5
13.6
17
5
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.0
13.6
69
264
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
22.2
13.5
19
9
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
13.2
164
959
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.7
13.1
45
135
N02AX02
ATC
tramadol; systemic, rectal
2.3
13.1
174
1046
ZXE00
NOMESCO Finland
One hour or less
2.2
12.7
175
1063
Q44.0
ICD-10 Finland
Agenesis, aplasia and hypoplasia of gallbladder
+∞
12.6
12
*
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
+∞
12.6
12
*
Q44.3
ICD-10 Finland
Congenital stenosis and stricture of bile ducts
+∞
12.6
12
*
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
+∞
12.6
12
*
R4190
NOMESCO Finland
Nutritional therapy
3.3
12.2
50
168
JN4AD
NOMESCO Finland
Body CT examination
3.0
12.2
60
225
N18.0
ICD-10 Finland
End-stage renal disease
27.8
12.1
16
6
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
14.0
12.1
20
15
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.4
12.0
47
153
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
12.0
57
209
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
11.7
166
1011
K83.1
ICD-10 Finland
Obstruction of bile duct
11.6
11.7
21
19
BE00A, ,
NOMESCO Finland
+∞
11.5
11
*
Q44.78
ICD-10 Finland
Other congenital malformations of the liver
+∞
11.5
11
*
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
17.7
11.3
17
10
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.7
11.0
23
28
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.2
10.9
23
47
C08CA02
ATC
felodipine; oral
3.3
10.9
43
141
L04AA01
ATC
[U] ciclosporin
18.5
10.8
16
9
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
29.0
10.8
14
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
10.8
53
198
XF602
NOMESCO Finland
Bloodpressure monitoring
13.4
10.8
18
14
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.5
10.6
20
20
WX882
NOMESCO Finland
High dependency care
3.8
10.6
33
92
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.2
10.5
29
74
K00.81
ICD-10 Finland
Color changes in the teeth caused by biliary anomalies
+∞
10.5
10
*
JJC10
NOMESCO Finland
Allogenic partial transplantation of liver
+∞
10.5
10
*
Q44.75
ICD-10 Finland
Focal nodular hypoplasia of the liver
+∞
10.5
10
*
Z3226
NOMESCO Finland
Physiotherapist
2.3
10.3
95
482
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
24.2
10.3
14
6
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
24.2
10.3
14
6
C03DA01
ATC
spironolactone; oral
2.8
10.3
58
233
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
8.3
10.3
22
28
V03AE01
ATC
polystyrene sulfonate; oral
13.6
10.3
17
13
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
11.8
10.2
18
16
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
41.3
10.0
12
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
26.9
9.9
13
5
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
20.7
9.9
14
7
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
9.5
9.6
19
21
UJK02
NOMESCO Finland
ERCP
5.4
9.5
19
37
Q61.99
ICD-10 Finland
Cystic kidney disease, unspecified
102.6
9.5
10
*
5AB14, ,
NOMESCO Finland
30.9
9.5
12
*
Q61.1
ICD-10 Finland
Polycystic kidney, autosomal recessive
+∞
9.4
9
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.6
9.3
32
96
A41.9
ICD-10 Finland
Sepsis, unspecified
4.5
9.3
23
54
UJF32
NOMESCO Finland
Coloscopy
2.1
9.1
108
603
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
9.1
102
558
V03AE03
ATC
lanthanum carbonate; oral
24.7
9.0
12
5
Z2221
NOMESCO Finland
Medical doctor
2.1
8.9
118
686
ZX120
NOMESCO Finland
Intravenous
2.6
8.9
54
225
J01MA12
ATC
levofloxacin; systemic
2.3
8.7
74
360
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.7
8.7
20
44
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
8.7
30
90
UJF30
NOMESCO Finland
Ileoscopy through colon
2.7
8.7
51
209
R18
ICD-10 Finland
Ascites
8.5
8.7
18
22
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.6
8.5
20
45
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
13.2
8.4
14
11
JJA30
NOMESCO Finland
Marsupialisation of cyst of liver
+∞
8.4
8
*
Q44.5
ICD-10 Finland
Other congenital malformations of bile ducts
+∞
8.4
8
*
7516D
ICD-9 Finland
Other congenital anomalies of digestive system, Anomalies of gallbladder, bile ducts and liver[HEPAR POLYCYSTICUM]
+∞
8.4
8
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
8.4
8
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.1
8.2
19
28
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
34.2
8.1
10
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
8.1
89
481
137
Kela drug reimbursment
Uraemia requiring dialysis
13.4
7.9
13
10
C08CA01
ATC
amlodipine; oral
1.9
7.9
143
922
602
Kela drug reimbursment
Children's severe malnutrition
6.6
7.8
19
30
C07AG02
ATC
carvedilol; oral
3.2
7.8
31
102
WX002
NOMESCO Finland
Sedation and analgesia
2.2
7.8
80
421
Q61.0
ICD-10 Finland
Congenital single renal cyst
46.0
7.7
9
*
JJA20
NOMESCO Finland
Open biopsy of liver
46.0
7.7
9
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
46.0
7.7
9
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
7.7
52
228
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
3.6
7.7
26
77
KBV00
NOMESCO Finland
Insertion of stent into ureter
18.8
7.6
11
6
KAC00
NOMESCO Finland
Nephrectomy
25.6
7.6
10
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
7.6
66
324
A41.8
ICD-10 Finland
Other specified sepsis
7.4
7.6
17
24
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.5
7.6
52
230
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.5
7.5
26
78
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.3
7.5
29
94
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
81.7
7.4
8
*
JK3AN
NOMESCO Finland
Biliary tract isotope imaging
81.7
7.4
8
*
K83.5
ICD-10 Finland
Biliary cyst
81.7
7.4
8
*
A02BC05
ATC
esomeprazole; systemic
1.8
7.4
153
1023
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
+∞
7.3
7
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.7
7.3
23
65
V03AG01
ATC
sodium cellulose phosphate; systemic
30.7
7.2
9
*
B01AB04
ATC
dalteparin; parenteral
3.5
7.1
24
71
3AC01, ,
NOMESCO Finland
11.2
6.8
12
11
XX6KT
NOMESCO Finland
Other sclerotherapy
40.8
6.8
8
*
4AA09, ,
NOMESCO Finland
40.8
6.8
8
*
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
40.8
6.8
8
*
TK810
NOMESCO Finland
Hemofiltration
23.0
6.7
9
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
23.0
6.7
9
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.2
6.7
18
45
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.3
6.7
25
79
C02AC05
ATC
moxonidine; oral
3.7
6.7
21
59
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
6.7
61
305
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.7
132
865
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
8.9
6.6
13
15
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
6.6
71
379
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
71.0
6.4
7
*
D97
ICPC
Liver disease NOS
14.6
6.4
10
7
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
14.6
6.4
10
7
Z49.2
ICD-10 Finland
Other dialysis
14.6
6.4
10
7
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
14.6
6.4
10
7
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
6.4
90
528
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
11.3
6.3
11
10
UKC02
NOMESCO Finland
Cystoscopy
2.2
6.3
55
270
T86.4
ICD-10 Finland
Liver transplant failure and rejection
+∞
6.3
6
*
JCA35
NOMESCO Finland
Endoscopic contact coagulation in oesophagus
+∞
6.3
6
*
A02BC01
ATC
omeprazole; systemic
1.9
6.3
98
595
WX892
NOMESCO Finland
Monitored bed care
2.6
6.2
36
146
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
3.2
6.2
25
83
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
8.8
6.1
12
14
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
6.9
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
94
51
24.41
122.71
3.5
3.4
4.00
84.08
u/ml
0.56
94
51
70
37
23.13
91.52
13.2
2.8
95.80
102.43
%
0.66
70
37
185
404
8.20
90.93
23.6
3.3
8.17
6.74
umol/l
0.63
178
350
81
75
13.57
78.42
14.2
7.9
348.27
176.67
iu/ml
—
26
9
99
133
9.82
73.35
3.3
3.2
354.50
1810.21
u/ml
0.75
90
117
69
65
12.83
65.66
12.5
5.4
21107.40
584.00
u/ml
—
10
9
103
182
7.47
59.49
18.1
12.3
1.57
1.21
mg/l
3.12
103
171
50
36
15.92
55.53
2.8
1.4
—
—
—
0
0
300
1423
7.00
55.49
19.9
5.5
35.81
36.14
g/l
0.56
292
1350
45
30
16.95
51.97
9.6
2.3
1.40
1.81
umol/l
1.40
45
25
51
43
13.61
51.65
18.5
1.9
34.26
10.45
umol/l
1.83
51
31
69
94
8.80
49.68
2.5
1.9
264.44
200.08
u/ml
0.62
54
37
68
93
8.74
48.77
3.0
1.7
—
—
—
0
0
69
97
8.52
48.35
2.4
1.9
—
—
—
0
0
66
91
8.62
46.95
3.0
1.7
134.31
127.12
au/ml
0.15
29
39
164
542
4.65
45.72
27.0
7.7
1.18
1.16
mmol/l
0.38
157
505
63
86
8.63
45.13
9.5
3.3
33.60
34.47
umol/l
0.10
58
79
279
1426
4.96
41.84
17.4
11.4
1.16
1.19
inr
0.67
233
1167
44
43
11.49
40.32
2.3
1.7
84.84
76.80
—
7
5
214
997
3.74
34.30
5.7
2.6
75.96
66.57
u/l
0.32
204
925
110
340
4.19
32.08
3.4
4.3
3.73
22.40
ug/l
0.86
77
279
103
314
4.17
30.47
6.9
2.2
46.40
31.57
u/l
1.57
90
255
180
813
3.38
29.07
5.0
2.5
—
—
—
0
0
154
643
3.40
28.11
6.1
3.2
0.45
1.00
e6/l
3.30
110
331
88
263
4.08
26.46
3.7
2.7
52.51
68.37
ml/min/173m2
1.78
30
112
282
1753
3.60
25.30
29.5
8.5
1.21
1.22
mmol/l
2.00
262
1538
309
2049
4.17
24.77
20.1
3.5
93.48
44.35
u/l
6.25
300
1937
116
436
3.42
24.63
16.3
8.4
104.87
104.29
mmol/l
0.56
116
436
266
1621
3.31
24.14
28.7
8.4
1.21
1.22
mmol/l
1.13
258
1507
141
606
3.15
23.84
6.3
3.4
1.72
2.43
e6/l
0.62
99
297
107
392
3.44
23.56
29.1
12.0
24.52
24.78
mmol/l
0.44
107
392
45
88
5.69
22.55
1.6
1.2
—
—
—
0
0
248
1486
3.05
22.51
5.4
2.9
—
—
estimate
—
0
0
29
10
31.32
22.22
5.4
3.0
0.58
0.60
mmol/l
—
29
10
162
778
2.93
22.15
7.6
3.2
333.02
331.67
umol/l
0.06
152
691
33
50
7.15
21.21
1.2
1.2
—
—
—
0
0
189
1012
2.78
20.65
9.3
3.5
0.10
0.38
e6/l
3.90
158
711
27
10
28.99
20.33
1.1
1.1
—
—
—
0
0
43
89
5.34
20.22
11.0
8.1
79.70
62.52
%
5.80
43
89
28
13
23.19
19.81
6.3
3.9
—
—
—
0
0
203
1167
2.65
18.67
9.4
3.6
19.94
95.37
e6/l
0.72
172
869
242
1543
2.66
17.57
7.0
2.8
80.59
77.15
nmol/l
1.42
231
1397
67
226
3.40
16.39
1.9
1.5
—
—
—
0
0
115
533
2.68
15.94
2.7
1.8
—
—
—
0
0
24
35
7.27
15.89
1.2
1.2
—
—
—
0
0
24
35
7.27
15.89
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
83
4.84
15.80
11.0
11.8
0.29
0.33
iu/ml
0.29
19
47
26
42
6.59
15.69
1.2
1.2
—
—
—
0
0
95
402
2.84
15.68
2.7
1.8
—
—
—
0
0
24
36
7.06
15.49
1.2
1.2
—
—
—
0
0
24
36
7.06
15.49
1.2
1.2
—
—
—
0
0
24
38
6.69
14.74
1.2
1.2
—
—
—
0
0
91
388
2.79
14.72
2.9
1.9
—
—
—
0
0
258
1782
2.50
14.48
7.5
3.9
0.00
0.00
estimate
-0.00
52
350
259
1796
2.49
14.34
7.5
3.9
0.00
4.51
estimate
0.50
50
360
82
337
2.84
14.18
15.0
9.3
-0.03
0.82
mmol/l
1.44
72
290
260
1812
2.48
14.14
7.5
4.0
0.00
0.90
estimate
0.50
53
336
19
8
24.94
13.93
1.1
1.1
—
—
—
0
0
156
886
2.32
13.53
3.9
2.6
2.57
2.87
mg/l
1.16
135
770
185
1135
2.27
13.27
5.8
3.7
6.47
7.52
mmol/l
2.78
173
962
276
2008
2.50
13.14
21.3
10.5
3.91
3.92
e9/l
0.03
249
1714
234
1595
2.28
12.82
6.7
3.2
114.77
99.18
ug/l
0.89
226
1494
132
741
2.22
11.38
7.9
2.5
1.68
1.46
mg/l
0.26
110
595
22
25
9.29
10.92
1.5
1.5
—
—
—
0
0
52
193
2.97
10.68
12.7
5.5
0.63
0.61
%
0.15
52
193
20
20
10.50
10.64
1.2
1.0
—
—
—
0
0
28
70
4.25
10.42
2.2
1.6
19.48
29.36
ng/l
1.04
28
70
32
90
3.80
10.17
2.3
1.6
—
—
—
0
0
70
314
2.52
9.96
4.0
3.3
—
—
—
0
0
48
181
2.90
9.57
2.7
1.7
—
—
—
0
0
302
2444
2.31
8.89
9.5
4.6
14.13
11.54
mm/h
2.40
290
2289
25
66
3.99
8.66
12.4
3.0
10.92
8.46
pmol/l
0.36
25
66
109
628
2.05
8.39
4.0
4.0
372.01
375.74
ng/l
0.01
92
475
21
51
4.31
8.11
1.4
1.4
—
—
—
0
0
197
1398
1.88
8.08
2.6
2.0
1.10
1.32
mmol/l
6.25
174
1183
30
95
3.35
8.00
3.7
2.7
4.95
6.70
index
0.15
21
53
167
1144
1.84
7.49
5.4
3.4
2.35
2.36
mmol/l
0.67
159
1042
29
95
3.23
7.34
2.0
3.7
1.36
2.06
ratio
0.58
14
52
342
3001
2.98
7.22
8.2
5.9
2.49
2.72
mmol/l
6.61
324
2794
31
107
3.07
7.20
1.8
1.3
—
—
—
0
0
30
103
3.08
7.03
2.1
4.0
47.22
30.37
mg/l
0.90
24
90
30
103
3.08
7.03
2.1
4.0
1529.05
99.49
mg/l
0.47
24
89
338
2966
2.71
6.80
7.7
5.2
4.39
4.66
mmol/l
5.68
322
2771
27
89
3.19
6.77
1.2
1.3
—
1.04
—
0
5
27
90
3.16
6.65
3.7
1.2
0.87
0.91
g/l
0.29
27
90
31
114
2.88
6.46
1.5
1.3
234.65
309.42
ug/g
1.13
20
68
27
92
3.09
6.41
1.2
1.2
—
—
—
0
0
354
3202
3.77
6.37
47.6
15.1
21.72
22.76
mg/l
0.30
330
2558
67
355
2.08
6.32
23.6
7.5
1.00
1.40
mmol/l
0.74
49
260
35
141
2.64
6.15
2.0
1.4
0.19
0.25
mg/l
—
9
54
147
1024
1.73
5.86
6.5
4.0
10.09
9.57
mg/mmol
0.05
116
614
11
12
9.41
5.82
1.2
1.0
1653.45
1341.25
miu/ml
0.32
11
12
54
275
2.13
5.63
25.0
8.0
10.16
9.14
kpa
3.32
54
268
333
2954
2.34
5.61
7.4
5.1
1.48
1.50
mmol/l
0.22
313
2743
134
921
1.72
5.55
1.9
1.7
19.61
21.55
nmol/l
0.93
121
766
117
775
1.75
5.52
6.2
3.8
1.02
1.02
kg/l
0.29
91
501
35
149
2.49
5.51
1.4
1.6
20.80
4.75
iu/ml
—
5
33
320
2801
2.09
5.49
6.3
4.3
1.16
1.25
mmol/l
1.85
300
2590
8
5
16.30
5.43
2.6
1.2
—
—
—
0
0
28
108
2.72
5.36
1.2
1.3
—
2.78
—
0
16
181
1367
1.64
5.12
2.4
2.1
93.41
96.27
pmol/l
0.42
100
676
18
55
3.39
5.09
1.4
1.1
2.42
1.38
u/ml
0.83
12
21
28
112
2.62
5.01
1.2
1.3
—
2.27
—
0
7
18
58
3.21
4.70
12.2
2.8
4.83
5.01
kpa
0.56
18
58
21
75
2.91
4.63
2.0
1.3
—
—
—
0
0
21
75
2.91
4.63
2.0
1.3
—
—
—
0
0
253
2115
1.63
4.44
3.5
3.2
—
—
—
0
0
9
13
7.07
4.18
1.7
2.2
269.67
3.99
ug/l
—
9
13
26
112
2.42
4.02
2.9
1.6
—
—
—
0
0
10
18
5.68
4.00
1.1
1.4
—
—
—
0
0
24
100
2.50
3.98
2.3
2.0
—
—
—
0
0
23
94
2.54
3.97
1.9
1.5
0.00
0.05
iu/ml
—
6
17
17
59
2.97
3.95
1.4
1.1
5.20
3.56
u/ml
—
10
27
11
23
4.90
3.90
4.4
2.8
1.55
0.70
index
0.86
11
23
315
2827
1.79
3.82
35.1
14.7
74.23
81.91
ml/min/173m2
5.30
297
2571
18
66
2.82
3.81
1.9
1.7
—
—
—
0
0
12
29
4.24
3.73
1.2
2.8
3.13
3.09
nmol/l
0.01
12
29
16
56
2.94
3.67
1.1
1.1
—
—
—
0
0
166
1302
1.50
3.57
7.1
3.7
0.00
0.01
estimate
0.99
46
299
7
9
7.90
3.57
1.1
1.1
—
—
—
0
0
6
6
10.14
3.51
4.2
6.8
—
—
—
0
0
130
974
1.52
3.46
8.1
3.9
0.00
0.00
estimate
-0.00
49
331
93
649
1.58
3.40
3.5
2.7
2.45
2.45
mmol/l
0.05
88
581
12
33
3.72
3.32
1.9
1.2
92.50
107.30
pmol/l
0.50
12
33
32
166
2.02
3.21
1.7
1.3
—
—
—
0
0
13
44
3.03
3.16
2.4
3.0
—
—
—
0
0
320
2929
1.71
3.04
6.7
5.1
5.77
5.89
mmol/l
0.74
305
2714
28
143
2.04
2.94
1.4
1.7
—
—
—
0
0
8
17
4.78
2.93
2.3
4.1
180.19
127.25
ug/l
—
8
17
313
2856
1.64
2.92
9.5
6.4
37.94
39.06
mmol/mol
1.46
304
2691
16
64
2.57
2.91
2.6
1.6
—
—
—
0
0
6
9
6.75
2.88
1.0
1.1
—
—
—
0
0
125
965
1.45
2.76
2.1
2.2
137.84
197.53
u/l
1.24
118
919
11
34
3.30
2.75
4.8
2.8
15.09
15.83
index
0.09
11
23
69
471
1.57
2.74
1.8
1.7
1102.54
1222.51
nmol/l
0.65
54
348
23
112
2.12
2.73
2.0
2.0
119.74
289.41
ug/l
1.87
23
104
24
119
2.09
2.73
4.0
1.6
—
—
—
0
0
10
29
3.51
2.71
1.2
1.1
—
—
—
0
0
10
30
3.40
2.62
1.2
1.1
—
—
—
0
0
16
68
2.41
2.59
1.7
1.4
—
—
—
0
0
18
82
2.26
2.51
2.3
1.6
—
—
—
0
0
72
515
1.49
2.31
1.6
1.5
—
—
—
0
0
20
99
2.08
2.31
1.4
1.3
88.25
279.96
miu/ml
—
8
40
12
47
2.61
2.29
2.1
1.5
—
—
—
0
0
8
23
3.53
2.28
2.5
1.4
—
—
—
0
0
8
23
3.53
2.28
1.3
3.3
1994.00
958.17
mg
—
8
23
7
19
3.73
2.16
5.1
2.8
828.57
595.30
ml
—
7
10
10
37
2.75
2.08
1.1
1.2
—
—
—
0
0
8
26
3.12
2.02
1.6
2.7
—
—
—
0
0
8
26
3.12
2.02
1.6
2.7
—
—
—
0
0
6
17
3.57
1.84
1.7
3.2
1704.50
751.24
u/ml
—
6
17
6
17
3.57
1.84
15.3
6.1
6.82
4.99
kpa
—
6
17
18
94
1.96
1.83
2.6
1.4
—
—
—
0
0
20
109
1.88
1.81
1.2
1.1
—
—
—
0
0
20
109
1.88
1.81
1.2
1.1
—
—
—
0
0
12
54
2.26
1.76
2.3
1.5
—
—
—
0
0
7
24
2.95
1.73
2.6
1.3
—
—
—
0
0
18
99
1.86
1.60
1.6
1.3
—
—
—
0
0
11
50
2.24
1.58
3.5
1.5
—
—
—
0
0
116
961
1.30
1.53
2.6
3.8
1792.98
1089.11
ng/l
0.86
109
819
7
28
2.53
1.46
1.0
1.0
—
—
—
0
0
19
111
1.75
1.42
1.7
1.9
—
—
—
0
0
133
1132
1.27
1.41
3.3
3.8
62.66
82.45
ng/l
0.11
97
788
12
62
1.97
1.29
1.3
1.3
—
—
—
0
0
5
18
2.80
1.29
4.0
1.3
120.60
64.10
ng/l
—
5
18
26
383
0.65
1.28
6.0
5.0
36.10
32.19
%
1.41
20
245
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
19
2.65
1.22
1.2
1.1
100.20
111.00
%
—
5
19
66
522
1.32
1.21
4.7
4.5
25.72
21.52
%
0.96
32
258
110
932
1.26
1.19
5.6
3.3
0.00
0.08
estimate
0.50
46
295
6
26
2.33
1.19
4.8
3.8
2.00
1.15
%
—
6
26
5
21
2.40
1.09
2.0
1.5
0.80
2.75
u/field
—
5
12
17
106
1.63
1.04
1.7
1.8
—
—
—
0
0
5
22
2.29
1.03
1.0
1.1
—
—
—
0
0
17
107
1.62
1.01
1.9
1.5
—
—
—
0
0
35
259
1.39
0.99
1.3
1.3
95.93
134.21
u/ml
0.31
12
100
14
222
0.62
0.98
2.1
2.1
11.96
12.90
nmol/l
0.13
14
205
31
226
1.41
0.96
1.0
1.1
—
—
—
0
0
112
978
1.21
0.90
1.4
1.5
2.98
2.39
u/ml
0.11
21
234
12
71
1.71
0.90
3.3
1.5
—
—
—
0
0
12
72
1.69
0.86
1.5
1.3
—
—
—
0
0
11
66
1.69
0.79
2.2
1.5
—
—
—
0
0
12
74
1.64
0.79
1.7
1.2
—
—
—
0
0
6
34
1.78
0.76
2.2
1.4
—
—
—
0
0
6
34
1.78
0.76
2.2
1.4
—
—
—
0
0
6
34
1.78
0.76
2.2
1.4
—
—
—
0
0
54
646
0.81
0.73
1.5
1.3
11.94
36.09
iu/ml
5.10
15
200
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
25
2.01
0.73
2.2
1.6
124.40
133.80
%
—
5
25
5
26
1.94
0.71
2.6
2.0
—
—
—
0
0
24
178
1.37
0.71
1.4
1.3
—
—
—
0
0
72
617
1.21
0.71
1.6
1.7
517.65
22328695.85
pmol/l
0.50
63
524
41
331
1.27
0.69
14.7
6.7
—
—
—
0
0
7
44
1.60
0.65
1.1
1.3
—
—
—
0
0
36
291
1.26
0.61
1.8
2.1
3.31
3.40
ratio
0.17
24
236
8
51
1.58
0.61
1.6
1.4
0.41
0.57
nmol/l
—
8
46
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
270
2591
1.16
0.59
4.5
4.5
14.93
14.74
pmol/l
0.67
257
2391
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
13
90
1.46
0.56
1.3
1.9
4.71
3.99
iu/l
—
7
38
6
38
1.59
0.54
1.0
1.3
—
—
—
0
0
47
400
1.20
0.51
3.8
3.1
0.84
0.77
ug/l
0.19
34
253
74
659
1.15
0.48
5.1
5.3
2.07
2.43
ug/l
0.30
69
598
27
218
1.26
0.48
1.7
1.9
3.26
3.51
mmol/l
0.46
15
160
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
0.13
—
0
17
306
2988
1.14
0.40
5.5
5.5
1.95
1.94
mu/l
0.04
294
2766
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
6
86
0.69
0.33
1.0
1.2
1.56
1.57
g/l
—
6
86
5
73
0.68
0.26
1.0
1.0
3.12
3.44
kpa
—
5
56
5
74
0.67
0.26
1.0
1.0
7.24
7.45
kpa
—
5
57
29
254
1.15
0.26
1.7
1.5
—
—
—
0
0
28
317
0.87
0.24
1.9
2.0
—
—
—
0
0
55
596
0.91
0.23
1.5
1.3
10.67
11.86
u/ml
0.04
25
226
13
107
1.22
0.22
1.8
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
13
108
1.21
0.20
1.2
1.2
—
13.91
—
0
17
0
14
0.00
0.20
0.0
1.3
—
9.14
—
0
14
5
69
0.72
0.17
1.0
1.1
—
2.19
—
0
5
11
129
0.85
0.15
1.1
1.1
—
6.00
—
0
8
7
86
0.81
0.14
1.0
1.4
—
—
—
0
0
8
98
0.81
0.14
1.5
1.6
—
—
—
0
0
32
341
0.93
0.10
1.9
2.1
—
—
—
0
0
5
47
1.06
0.09
2.2
1.3
—
—
—
0
0
5
48
1.04
0.09
2.4
1.3
—
—
—
0
0
5
48
1.04
0.09
2.4
1.3
—
—
—
0
0
8
95
0.84
0.06
2.5
3.0
—
—
—
0
0
18
192
0.93
0.05
2.1
1.9
—
—
—
0
0
75
760
0.98
0.02
2.0
1.8
—
—
—
0
0
13
125
1.04
0.00
1.1
1.3
—
—
—
0
0
16
155
1.03
0.00
1.9
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
89
1.01
-0.00
1.1
2.4
3.40
3.79
mmol/l
—
9
83
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
10.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
59
1.02
-0.00
1.0
1.1
—
184.93
—
0
15
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_GALLB_BILE_DUCTS_LIVER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_GALLB_BILE_DUCTS_LIVER | 1.328 [1.1, 1.6] | 0.003 |
| Birth year | 1.002 [0.99, 1.01] | 0.663 |
During the follow-up period (1.1.1998 — 31.12.2019), 200 out of 1032 females with Q17_CONGEN_MALFO_GALLB_BILE_DUCTS_LIVER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_GALLB_BILE_DUCTS_LIVER | 1.368 [1.01, 1.86] | 0.044 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 130 out of 506 males with Q17_CONGEN_MALFO_GALLB_BILE_DUCTS_LIVER died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_GALLB_BILE_DUCTS_LIVER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.181% | 0.232% |
| 5 | 1.032% | 1.42% |
| 10 | 2.439% | 3.794% |
| 15 | 4.731% | 7.375% |
| 20 | 8.411% | 12.237% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_GALLB_BILE_DUCTS_LIVER – Congenital malformations of gallbladder, bile ducts and liver
GWS hits: 15
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data